MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $151 | -54.5% | 38,609 | -51.3% | 0.00% | – |
Q1 2024 | $332 | -48.8% | 79,232 | -42.5% | 0.00% | – |
Q4 2023 | $648 | +561.2% | 137,831 | +336.7% | 0.00% | – |
Q3 2023 | $98 | -38.4% | 31,565 | -9.6% | 0.00% | – |
Q2 2023 | $159 | -58.8% | 34,924 | -55.2% | 0.00% | – |
Q1 2023 | $386 | +132.5% | 77,878 | +154.5% | 0.00% | – |
Q4 2022 | $166 | -99.8% | 30,597 | +172.7% | 0.00% | – |
Q3 2022 | $72,000 | +18.0% | 11,220 | -12.3% | 0.00% | – |
Q2 2022 | $61,000 | -73.8% | 12,792 | -61.5% | 0.00% | – |
Q1 2022 | $233,000 | +870.8% | 33,229 | +1296.2% | 0.00% | – |
Q4 2021 | $24,000 | +60.0% | 2,380 | +95.2% | 0.00% | – |
Q3 2021 | $15,000 | – | 1,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |